Scarica l'app Stockscreener
2.54
0.79%
0.02
Dopo l'orario di chiusura:
2.59
0.05
+1.97%
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché PHIO Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$2.52
Aprire:
$2.47
Volume 24 ore:
33,088
Relative Volume:
0.06
Capitalizzazione di mercato:
$12.19M
Reddito:
-
Utile/perdita netta:
$-11.66M
Rapporto P/E:
-0.3114
EPS:
-8.156
Flusso di cassa netto:
$-11.09M
1 W Prestazione:
+6.72%
1M Prestazione:
+16.51%
6M Prestazione:
+8.55%
1 anno Prestazione:
-32.63%
Intervallo 1D:
$2.47
$2.57
Intervallo di 1 settimana:
$2.35
$2.57
Portata 52W:
$0.9657
$9.79
Phio Pharmaceuticals Corp Stock (PHIO) Company Profile
Nome
Phio Pharmaceuticals Corp
Settore
Industria
Telefono
(508) 767-3861
Indirizzo
11 APEX DRIVE, SUITE 300A, MARLBOROUGH, MA
Confronta PHIO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PHIO
Phio Pharmaceuticals Corp
|
2.54 | 12.09M | 0 | -11.66M | -11.09M | -8.156 |
|
VRTX
Vertex Pharmaceuticals Inc
|
476.95 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.39 | 60.56B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.64 | 42.41B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
575.42 | 34.96B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.83 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Phio Pharmaceuticals Corp Stock (PHIO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-05 | Ripresa | H.C. Wainwright | Buy |
| 2020-08-05 | Iniziato | H.C. Wainwright | Buy |
Phio Pharmaceuticals Corp Borsa (PHIO) Ultime notizie
Is Phio Pharmaceuticals Corp. a good long term investmentBreakout stock performance - jammulinksnews.com
What analysts say about Phio Pharmaceuticals Corp. stockUnmatched market performance - Autocar Professional
Phio Pharmaceuticals Corp. Stock Analysis and ForecastAccelerated wealth expansion - jammulinksnews.com
What drives Phio Pharmaceuticals Corp. stock priceSuperior returns - jammulinksnews.com
Phio Pharmaceuticals shares rise 1.26% premarket after closing a public offering of 10,000,000 shares. - AInvest
Why Phio Pharmaceuticals Corp. stock attracts strong analyst attentionHigh Reward Risk Balanced Trading - Newser
What makes Phio Pharmaceuticals Corp. stock price move sharplySmart Growth Low Risk Picks - Newser
How Phio Pharmaceuticals Corp. stock performs during market volatilityFree Financial Group - Newser
Phio Pharmaceuticals Announces 2025 Annual Meeting Details - The Globe and Mail
Phio Pharmaceuticals (NASDAQ:PHIO) Stock Price Up 6.3% – Here’s Why - Defense World
Phio Pharma stock maintains buy rating as cancer trial advances - Investing.com
Phio’s PH-762 shows positive safety profile in fourth cohort trial - Investing.com
Breakthrough: Phio's Skin Cancer Treatment Shows Positive Results in Phase 1b Trial, CEO Details Progress - Stock Titan
Phio Pharmaceuticals Announces Strategic Initiative and Leadership Changes - TipRanks
Phio Pharmaceuticals Appoints Lisa Carson As Principal Financial OfficerSEC Filing - MarketScreener
Research Analysts Set Expectations for PHIO FY2025 Earnings - Defense World
What is HC Wainwright’s Forecast for PHIO Q2 Earnings? - Defense World
Phio Pharmaceuticals appoints new strategic and finance VPs By Investing.com - Investing.com South Africa
Phio Pharmaceuticals appoints new strategic and finance VPs - Investing.com India
Phio Pharmaceuticals Announces Strategic Initiative to Create Awareness of the Comprehensive INTASYL siRNA Portfolio - TradingView
Phio Pharmaceuticals Advances 30-Drug Cancer Portfolio as Phase 1b Trial Shows Promise - Stock Titan
Phio Pharmaceuticals (NASDAQ:PHIO) Now Covered by HC Wainwright - Defense World
Phio Pharma (PHIO) Receives Buy Rating and $14 Price Target from HC Wainwright | PHIO Stock News - GuruFocus
H.C. Wainwright assumes coverage on Phio Pharma stock with Buy rating - Investing.com India
Phio Pharmaceuticals (PHIO) Gains 'Buy' Rating with Promising Pr - GuruFocus
2 No-Brainer Artificial Intelligence (AI) Stocks to Buy Right Now - The Globe and Mail
Why BioNTech Stock Soared Today - The Globe and Mail
Best Value Stocks to Buy for May 28th - The Globe and Mail
Phio Pharmaceuticals Corp Azioni (PHIO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
4.91%
0.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):